PSB-10
Systematic (IUPAC) name | |
---|---|
(8R)-ethyl-4-methyl-2-(2,3,5-trichlorophenyl)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]purin-5-one
|
|
Identifiers | |
CAS Number | 591771-91-4 |
PubChem | CID: 10318703 |
IUPHAR/BPS | 5619 |
ChemSpider | 8494167 |
ChEMBL | CHEMBL1562432 |
Synonyms | PSB-10 |
Chemical data | |
Formula | C16H14Cl3N5O |
Molecular mass | 400.690 g/mol |
|
|
|
|
(what is this?) (verify) |
PSB-10 is a drug which acts as a selective antagonist[1] for the adenosine A3 receptor (ki value at human A3 receptor is 0.44 nM), with high selectivity over the other three adenosine receptor subtypes (ki values at human A1, A2A and A2B receptors are 4.1, 3.3 and 30 µM). Further pharmacological experiments in a [35S]GTPγS binding assay using hA3-CHO-cells indicated that PSB-10 acts as an inverse agonist (IC50 = 4 nM). It has been shown to produce antiinflammatory effects in animal studies.[2] Simple xanthine derivatives such as caffeine and DPCPX have generally low affinity for the A3 subtype and must be extended by expanding the ring system and adding an aromatic group to give high A3 affinity and selectivity.[3] The affinity towards adenosine A3 subtype was measured against the radioligand PSB-11.[4]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Chloroarenes
- Purines
- Lactams
- Adenosine receptor antagonists
- Nervous system drug stubs